Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.00165046763249594 9.16926462498177E-05 -0.000458463231248828
Stock impact report

U.S. FDA declines to approve Revance's frown-line treatment [Reuters]

AbbVie Inc. (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
Company Research Source: Reuters
drug to treat moderate to severe frown lines, sending its shares plunging 29%. The company said the FDA pointed to "deficiencies" related to the regulator's inspection of Revance's manufacturing site. No other concerns were raised in the agency's "complete response letter", the drug developer said. Revance's DaxibotulinumtoxinA for Injection, a potential rival for AbbVie Inc's (ABBV.N) Botox anti-wrinkle injection, was successful in reducing moderate to severe frown lines in a late-stage study in December 2018. In November last year, the U.S. FDA delayed its decision on the drug, as it was unable to conduct required inspection of the company's manufacturing facility due to COVID-19 travel restrictions. Revance later said it was expecting approval in 2021. "We are very disappointed by this unanticipated response from the FDA and are seeking further clarity from the agency," Mark Foley, the chief executive officer of Revance, said in a statement on Friday. Revance said it pl Show less Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ABBV alerts
Opt-in for
ABBV alerts

from News Quantified
Opt-in for
ABBV alerts

from News Quantified